Standard Chem. & Pharm. CO.,LTD.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022

In its 2023 reporting, Standard Chem. & Pharm. CO.,LTD. disclosed greenhouse gas emissions of 8.5K tCO2e/year (Scope 1+2). By scope: Scope 1: 7.9K tCO2e/year; Scope 3: 649 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
8.5K tCO2e/year (Scope 1+2)
2023
💧
Water Usage
164.923 m3/year
2023
♻️
Waste
394.53 tons/year
2023
⚙️
Energy Use
72.4K MWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).7.9K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).649 tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
20238.5K tCO2e/year (Scope 1+2)
20228.9K tCO2e/year (Scope 1+2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Achieve a declared green procurement amount of 1 million dollars in 2023.
  • Continuously update relevant policies, conduct regular education and training, and enhance employee awareness (Integrity, Greenhouse Gas Emissions, Product Quality).

📅 Medium-term

  • Achieve a stable annual reduction of 1% in greenhouse gas emissions.
  • Establish an internal culture of integrity.
  • Analyze adverse events, track causes, and update the management system (Product Quality).
  • Conduct annual employee satisfaction surveys and propose improvement plans (Talent Cultivation).

🔭 Long-term

  • Achieve carbon neutrality.
  • Build a robust integrity risk management system.
  • Become a market leader in quality excellence.
  • Cultivate and retain high-potential talents.

🌱 ESG Focus Areas

Corporate GovernanceEnvironmental SustainabilityEmployee RelationsSocial CareProduct Quality and ResponsibilityIntegrity in BusinessGreenhouse Gas Emissions, Climate Change Adaptation, and Energy ManagementTalent Cultivation and DevelopmentSocial Engagement

⚠️ Challenges & Risks +

  • Price controls, sales restrictions, and global competition in the generic medicine industry.
  • Uncertainty in the pharmaceutical supply chain due to globalization to localization shifts.
  • Climate change impacts (extreme weather, energy costs, water scarcity).
  • Increased waste generation in 2022 due to high production volume.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI Standards